Eli Lilly stock jumps after $1.2B Ventyx buy as obesity-pill bets come into focus
New York, Jan 7, 2026, 4:55 PM EST — After-hours Eli Lilly and Co shares climbed on Wednesday after the drugmaker agreed to buy Ventyx Biosciences in a $1.2 billion deal, pressing ahead with its push beyond blockbuster diabetes and weight-loss drugs. Lilly stock ended up 4.1% at $1,108.09, after touching $1,117.37, for a market value around $1 trillion. Reuters…